Rallybio Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rallybio Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Rallybio Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $78.3M, a 55.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $78.3M +$28.1M +55.9% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $50.2M +$19.1M +61.1% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $31.2M +$15.8M +103% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $15.3M Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.